Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS

European Journal of Immunology

Volumn 36, Issue 3, 2006, Pages 613-622

  Stiles, Linda N ^a   Hosking, Martin P ^a   Edwards, Robert A ^a,b   Strieter, Robert M ^c   Lane, Thomas E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell trafficking; Chemokine receptors; Inflammation; T cell; Virus

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMYELINATING DISEASE; ENCEPHALOMYELITIS; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HOST RESISTANCE; INFECTION RESISTANCE; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHEMOKINES, CXC; CHRONIC DISEASE; DEMYELINATING DISEASES; ENCEPHALOMYELITIS; INFLAMMATION; MICE; MICE, INBRED BALB C; MURINE HEPATITIS VIRUS; RECEPTORS, CHEMOKINE;

EID: 33644952574     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535509     Document Type: Article

References (43)

1. Thelen, M., Dancing to the tune of chemokines. Nat. Immunol. 2001. 2: 129-134.
2. Moser, B. and Loetscher, P., Lymphocyte traffic control by chemokines. Nat. Immunol. 2001. 2: 123-128.
3. Luther, S. A. and Cyster, J. G., Chemokines as regulators of T cell differentiation. Nat. Immunol. 2001. 2: 102-107.
4. Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M. and Moser, B., Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 1996. 184: 963-969.
5. Loetscher, M., Loetscher, P., Brass, N., Meese, E. and Moser, B., Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur. J. Immunol. 1998. 28: 3696-3705.
6. Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E. et al., The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 1998. 101: 746-754.
7. Trebst, C., Staugaitis, S. M., Tucky, B., Wei, T., Suzuki, K., Aldape, K. D., Pardo, C. A. et al., Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS). Neuropathol. Appl. Neurobiol. 2003. 29: 584-595.
8. Marten, N. W., Stohlman, S. A. and Bergmann, C. C., MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol. 2001. 14: 1-18.
9. Lane, T. E., Asensio, V. C., Yu, N., Paoletti, A. D., Campbell, I. L. and Buchmeier, M. J., Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J. Immunol. 1998. 160: 970-978.
10. Adami, C., Pooley, J., Glomb, J., Stecker, E., Fazal, F., Fleming, J. O. and Baker, S. C., Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology 1995. 209: 337-346.
11. Fleming, J. O., Trousdale, M. D., el-Zaatari, F. A., Stohlman, S. A. and Weiner, L. P., Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 1986. 58: 869-875.
12. Fleming, J. O., Houtman, J. J., Alaca, H., Hinze, H. C., McKenzie, D., Aiken, J., Bleasdale, T. and Baker, S., Persistence of viral RNA in the central nervous system of mice inoculated with MHV-4. Adv. Exp. Med. Biol. 1993. 342: 327-332.
13. McIntosh, K., Fields Virology, 3rd Edn. Lippincott-Raven Publishers 1996, pp 401-430.
14. Lane, T. E., Liu, M. T., Chen, B. P., Asensio, V. C., Samawi, R. M., Paoletti, A. D., Campbell, I. L. et al., A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J. Virol. 2000. 74: 1415-1424.
15. Wu, G. F., Dandekar, A. A., Pewe, L. and Perlman, S., CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J. Immunol. 2000. 165: 2278-2286.
16. Wang, F. I., Stohlman, S. A. and Fleming, J. O., Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J. Neuroimmunol. 1990. 30: 31-41.
17. Lin, M. T., Hinton, D. R., Marten, N. W., Bergmann, C. C. and Stohlman, S. A., Antibody prevents virus reactivation within the central nervous system. J. Immunol. 1999. 162: 7358-7368.
18. Liu, M. T., Chen, B. P., Oertel, P., Buchmeier, M. J., Armstrong, D., Hamilton, T. A. and Lane, T. E., The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J. Immunol. 2000. 165: 2327-2330.
19. Liu, M. T., Keirstead, H. S. and Lane, T. E., Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J. Immunol. 2001. 167: 4091-4097.
20. Chen, B. P., Kuziel, W. A. and Lane, T. E., Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J. Immunol. 2001. 167: 4585-4592.
21. Glass, W. G., Liu, M. T., Kuziel, W. A. and Lane, T. E., Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus. Virology 2001. 288: 8-17.
22. Glass, W. G., Hickey, M. J., Hardison, J. L., Liu, M. T., Manning, J. E. and Lane, T. E., Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J. Immunol. 2004. 172: 4018-4025.
23. Liu, M. T., Armstrong, D., Hamilton, T. A. and Lane, T. E., Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J. Immunol. 2001. 166: 1790-1795.
24. Held, K. S., Chen, B. P., Kuziel, W. A., Rollins, B. J. and Lane, T. E., Differential roles of CCL2 and CCR2 in host defense to coronavirus infection. Virology 2004. 329: 251-260.
25. Houtman, J. J. and Fleming, J. O., Pathogenesis of mouse hepatitis virus-induced demyelination. J. Neurovirol. 1996. 2: 361-376.
26. Wang, F. I., Hinton, D. R., Gilmore, W., Trousdale, M. D. and Fleming, J. O., Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab. Invest. 1992. 66: 744-754.
27. Haspel, M. V., Lampert, P. W. and Oldstone, M. B., Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc. Natl. Acad. Sci. USA 1978. 75: 4033-4036.
28. Weiner, L. P., Pathogenesis of demyelination induced by a mouse hepatitis. Arch. Neurol. 1973. 28: 298-303.
29. Christensen, J. E., Nansen, A., Moos, T., Lu, B., Gerard, C., Christensen, J. P. and Thomsen, A. R., Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3. J. Neurosci. 2004. 24: 4849-4858.
30. + T cell-mediated inflammation in the central nervous system of virus-infected mice. J. Immunol. 2005. 175: 1767-1775.
31. + T cells. J. Virol. 1990. 64: 4589-4592.
32. Parra, B., Hinton, D. R., Marten, N. W., Bergmann, C. C., Lin, M. T., Yang, C. S. and Stohlman, S. A., IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 1999. 162: 1641-1647.
33. Lin, M. T., Stohlman, S. A. and Hinton, D. R., Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J. Virol. 1997. 71: 383-391.
34. Belperio, J. A., Keane, M. P., Burdick, M. D., Lynch, J. P., 3rd, Xue, Y. Y., Li, K., Ross, D. J. and Strieter, R. M., Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J. Immunol. 2002. 169: 1037-1049.
35. Frigerio, S., Junt, T., Lu, B., Gerard, C., Zumsteg, U., Hollander, G. A. and Piali, L., Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. Med. 2002. 8: 1414-1420.
36. Hildebrandt, G. C., Corrion, L. A., Olkiewicz, K. M., Lu, B., Lowler, K., Duffner, U. A., Moore, B. B. et al., Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. J. Immunol. 2004. 173: 2050-2059.
37. Whiting, D., Hsieh, G., Yun, J. J., Banerji, A., Yao, W., Fishbein, M. C., Belperio, J. et al., Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J. Immunol. 2004. 172: 7417-7424.
38. Dufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E. and Luster, A. D., IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 2002. 168: 3195-3204.
39. + T cells following coronavirus infection of the central nervous system. Virology 2003. 312: 407-414.
40. Glass, W. G. and Lane, T. E., Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease. J. Virol. 2003. 77: 191-198.
41. Marten, N. W., Hohman, M., Stohlman, S. A., Atkinson, R. D., Hinton, D. R. and Bergmann, C. C., Acute CNS infection is insufficient to mediate chronic T cell retention. Adv. Exp. Med. Biol. 2001. 494: 349-354.
42. + -T-cell expansion and trafficking following central nervous system infection. J. Virol. 2003. 77: 2775-2778.
43. Dalziel, R. G., Lampert, P. W., Talbot, P. J. and Buchmeier, M. J., Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 1986. 59: 463-471.